BBC Holdings — Virtus LifeSci Biotech Clinical Trials ETF
All 125 reported holdings of Virtus LifeSci Biotech Clinical Trials ETF (BBC) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Dreyfus Government Cash Manage | 2.28% | $852.19K |
| Erasca, Inc. | 2.19% | $816.51K |
| Enliven Therapeutics, Inc. | 1.81% | $674.94K |
| Tango Therapeutics, Inc. | 1.71% | $638.18K |
| Oruka Therapeutics, Inc. | 1.68% | $625.47K |
| Spyre Therapeutics, Inc. | 1.64% | $611.09K |
| Alumis, Inc. | 1.59% | $593.05K |
| Dianthus Therapeutics, Inc. | 1.54% | $575.18K |
| Kodiak Sciences, Inc. | 1.35% | $503.98K |
| Revolution Medicines, Inc. | 1.35% | $503.84K |
| Corvus Pharmaceuticals, Inc. | 1.34% | $500.91K |
| Rezolute, Inc. | 1.31% | $490.68K |
| Definium Therapeutics, Inc. | 1.29% | $481.21K |
| Cg Oncology, Inc. | 1.21% | $449.89K |
| Jade Biosciences, Inc. | 1.20% | $449.57K |
| Inhibrx Biosciences, Inc. | 1.20% | $447.97K |
| Relay Therapeutics, Inc. | 1.19% | $445.45K |
| Gh Research PLC | 1.16% | $434.72K |
| Nektar Therapeutics | 1.15% | $429.03K |
| Tyra Biosciences, Inc. | 1.14% | $423.81K |
| Vir Biotechnology, Inc. | 1.13% | $421.43K |
| Intellia Therapeutics, Inc. | 1.10% | $412.47K |
| Centessa Pharmaceuticals PLC | 1.10% | $410.40K |
| Anaptysbio, Inc. | 1.08% | $403.52K |
| Omeros Corp. | 1.06% | $397.00K |
| Tectonic Therapeutic, Inc. | 1.05% | $390.63K |
| Allogene Therapeutics, Inc. | 1.04% | $389.34K |
| Compass Pathways PLC | 0.99% | $371.01K |
| Edgewise Therapeutics, Inc. | 0.97% | $361.77K |
| Palvella Therapeutics, Inc. | 0.96% | $359.04K |
| Capricor Therapeutics, Inc. | 0.95% | $356.15K |
| Vaxcyte, Inc. | 0.95% | $354.95K |
| Pharvaris NV | 0.95% | $354.26K |
| Arrivent Biopharma, Inc. | 0.94% | $351.32K |
| Xenon Pharmaceuticals, Inc. | 0.94% | $351.03K |
| Neurogene, Inc. | 0.92% | $344.21K |
| Summit Therapeutics, Inc. | 0.90% | $337.09K |
| Amylyx Pharmaceuticals, Inc. | 0.90% | $337.09K |
| Celldex Therapeutics, Inc. | 0.88% | $329.85K |
| Praxis Precision Medicines, Inc. | 0.88% | $327.12K |
| Arcus Biosciences, Inc. | 0.88% | $326.88K |
| Annexon, Inc. | 0.87% | $325.99K |
| Terns Pharmaceuticals, Inc. | 0.87% | $324.57K |
| Liquidia Corp. | 0.87% | $324.19K |
| Monte Rosa Therapeutics, Inc. | 0.87% | $324.06K |
| Immunome, Inc. | 0.87% | $323.50K |
| Bicara Therapeutics, Inc. | 0.86% | $322.28K |
| Celcuity, Inc. | 0.85% | $318.06K |
| Ironwood Pharmaceuticals, Inc. | 0.85% | $318.03K |
| Abcellera Biologics, Inc. | 0.85% | $316.42K |
| Precigen, Inc. | 0.83% | $311.16K |
| Belite Bio, Inc. | 0.83% | $310.68K |
| Beam Therapeutics, Inc. | 0.82% | $305.94K |
| Moonlake Immunotherapeutics | 0.82% | $305.67K |
| Taysha Gene Therapies, Inc. | 0.82% | $304.60K |
| Cullinan Therapeutics, Inc. | 0.81% | $302.15K |
| Immatics NV | 0.81% | $302.12K |
| Rapport Therapeutics, Inc. | 0.81% | $302.08K |
| Zymeworks, Inc. | 0.80% | $298.31K |
| Apogee Therapeutics, Inc. | 0.79% | $296.75K |
| Prothena Corp. PLC | 0.79% | $294.66K |
| Oric Pharmaceuticals, Inc. | 0.78% | $290.71K |
| Denali Therapeutics, Inc. | 0.77% | $287.37K |
| Protagonist Therapeutics, Inc. | 0.77% | $286.42K |
| Meiragtx Holdings PLC | 0.76% | $285.29K |
| Immunovant, Inc. | 0.76% | $283.56K |
| Rocket Pharmaceuticals, Inc. | 0.76% | $283.33K |
| Uniqure NV | 0.76% | $282.23K |
| Soleno Therapeutics, Inc. | 0.75% | $280.26K |
| Mbx Biosciences, Inc. | 0.75% | $279.29K |
| Stoke Therapeutics, Inc. | 0.75% | $278.81K |
| Cytokinetics, Inc. | 0.75% | $278.59K |
| Cytomx Therapeutics, Inc. | 0.74% | $277.98K |
| Scholar Rock Holding Corp. | 0.74% | $274.44K |
| Ataibeckley, Inc. | 0.72% | $267.64K |
| Nuvalent, Inc. | 0.71% | $264.04K |
| Janux Therapeutics, Inc. | 0.69% | $259.21K |
| Septerna, Inc. | 0.69% | $257.77K |
| Dyne Therapeutics, Inc. | 0.67% | $251.35K |
| Sionna Therapeutics, Inc. | 0.67% | $249.73K |
| Kymera Therapeutics, Inc. | 0.67% | $249.45K |
| Arbutus Biopharma Corp. | 0.66% | $246.12K |
| Nurix Therapeutics, Inc. | 0.65% | $241.70K |
| Prime Medicine, Inc. | 0.64% | $238.65K |
| Prokidney Corp. | 0.64% | $237.29K |
| Engene Therapeutics, Inc. | 0.64% | $237.18K |
| Ideaya Biosciences, Inc. | 0.63% | $236.06K |
| Xeris Biopharma Holdings, Inc. | 0.63% | $235.78K |
| Cogent Biosciences, Inc. | 0.63% | $234.57K |
| Viking Therapeutics, Inc. | 0.62% | $232.07K |
| Biohaven Ltd. | 0.61% | $229.57K |
| Eyepoint, Inc. | 0.61% | $227.83K |
| 4d Molecular Therapeutics, Inc. | 0.60% | $225.84K |
| Recursion Pharmaceuticals, Inc. | 0.59% | $220.55K |
| Arvinas, Inc. | 0.58% | $217.21K |
| Newamsterdam Pharma Company NV | 0.57% | $211.57K |
| Savara, Inc. | 0.56% | $209.00K |
| Assembly Biosciences, Inc. | 0.55% | $206.03K |
| Xencor, Inc. | 0.53% | $199.31K |
| Mineralys Therapeutics, Inc. | 0.53% | $199.29K |
| Disc Medicine, Inc. | 0.53% | $198.11K |
| Vera Therapeutics, Inc. | 0.53% | $197.32K |
| Rigel Pharmaceuticals, Inc. | 0.52% | $195.54K |
| Monopar Therapeutics, Inc. | 0.52% | $192.90K |
| Maze Therapeutics, Inc. | 0.51% | $188.77K |
| Regenxbio, Inc. | 0.48% | $178.50K |
| Sana Biotechnology, Inc. | 0.47% | $176.67K |
| Bicycle Therapeutics PLC | 0.47% | $174.86K |
| Structure Therapeutics, Inc. | 0.46% | $170.57K |
| Invivyd, Inc. | 0.45% | $166.56K |
| Lexeo Therapeutics, Inc. | 0.43% | $160.88K |
| Verastem, Inc. | 0.42% | $156.81K |
| Fulcrum Therapeutics, Inc. | 0.41% | $151.37K |
| First Tracks Biotherapeutics, Inc. | 0.38% | $142.85K |
| Keros Therapeutics, Inc. | 0.38% | $142.67K |
| Altimmune, Inc. | 0.36% | $136.17K |
| Zenas Biopharma, Inc. | 0.35% | $131.36K |
| Olema Pharmaceuticals, Inc. | 0.32% | $120.34K |
| Wave Life Sciences Ltd. | 0.32% | $117.65K |
| Viridian Therapeutics, Inc. | 0.31% | $115.15K |
| Compass Therapeutics, Inc. | 0.25% | $94.68K |
| Upstream Bio, Inc. | 0.25% | $93.35K |
| Replimune Group, Inc. | 0.19% | $69.68K |
| Mereo Biopharma Group PLC | 0.09% | $34.14K |
| Gossamer Bio, Inc. | 0.08% | $28.20K |